GlassScriptPhysician profile
Samantha M Weiss
NPI 1619403714
$1,395.01
in general payments reported to CMS, 2019-2025
14 companies · $212 in 2025
The $212 reported for 2025 was more than what 76% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $278 · 2023: $485 · 2024: $256 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $357.85 | 2021-2025 | Lifevest |
| Pfizer INC. | $250.74 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $239.82 | 2021-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $207.58 | 2021-2024 | Eliquis |
| Amgen INC. | $163.20 | 2022-2024 | Repatha |
| Actelion Pharmaceuticals US, INC. | $26.28 | 2025 | Opsynvi |
| Heartflow, INC. | $23.62 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.61 | 2023 | Jardiance |
| Esperion Therapeutics, INC. | $20.61 | 2021 | |
| Boston Scientific Corporation | $19.29 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.93 | 2021 | |
| Amarin Pharma, INC. | $16.80 | 2022 | |
| Scpharmaceuticals INC. | $15.89 | 2024 | |
| Tactile Systems Technology INC | $15.79 | 2023 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.